These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9362132)
1. Effect of adenoviral-mediated thymidine kinase transduction and ganciclovir therapy on tumor-associated endothelial cells. Tanaka T Neurol Med Chir (Tokyo); 1997 Oct; 37(10):730-7; discussion 737-8. PubMed ID: 9362132 [TBL] [Abstract][Full Text] [Related]
2. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells. Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379 [TBL] [Abstract][Full Text] [Related]
3. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433 [TBL] [Abstract][Full Text] [Related]
4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
7. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368 [TBL] [Abstract][Full Text] [Related]
8. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium]. Wang B; Weng J Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913 [TBL] [Abstract][Full Text] [Related]
9. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line]. Huang H; Wang A Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
11. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells]. Liu XP; Li BJ; Zhang C Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582 [TBL] [Abstract][Full Text] [Related]
12. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
13. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors. Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121 [TBL] [Abstract][Full Text] [Related]
14. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736 [TBL] [Abstract][Full Text] [Related]
16. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy]. Zhang L; Liu T; Cui Q; Gao J Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559 [TBL] [Abstract][Full Text] [Related]